Stock AnalizAveanna Healthcare Holdings, Inc. AVAH
Medical/Nursing Services · IPO 2021 · data as of November 13, 2026
Aveanna Healthcare Holdings, Inc. (AVAH) is a healthcare company listed in the US with a market value of about $2.5B. In the twelve months to October 3, 2026 it had revenue of $2.7B and net income of $306M, a net margin of 11.4%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is financial health (1/5).
Key numbers: a P/E of 8.2, a price to free cash flow of 12.7, 5-year revenue growth of 10% a year, a 5-year average ROIC of -5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 38% below the current price.
Score: 2.2 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.4B | $2.0B | $1.9B | $1.8B | $1.7B | $1.5B | $1.4B |
| Net income | $306M | $225M | -$11M | -$135M | -$662M | -$117M | -$57M | -$77M |
| Free cash flow | $198M | — | — | — | — | -$27M | $101M | -$25M |
| EPS (diluted) | $1.40 | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.00 | $-0.00 | $-0.00 |
| Net margin | 11.4% | 9.2% | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% | -5.5% |
| ROIC | — | 13.2% | 9.2% | 0.7% | -47.7% | -1.5% | -0.2% | 11.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 10 analysts is $15.20, 32% above the current price; targets range from $13.00 to $16.00; the consensus rating is “Buy”; expected EPS is $0.84 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Aveanna Healthcare’s P/E ratio?
About 8.2, based on the last twelve months of diluted earnings per share (forward P/E about 13.1).
Is Aveanna Healthcare stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 38% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Aveanna Healthcare pay a dividend?
Not currently.
Is Aveanna Healthcare a good stock to buy?
We do not give buy or sell advice. Aveanna Healthcare scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.